Pfizer DMD Gene Therapy Phase III Trial Faces A US Delay; Can Sarepta Close The Gap?

Sarepta Hopes To Meet With FDA Midyear

 
• By Jessica Merrill
Boat Race
Pfizer and Sarepta are in a race to develop a DMD gene therapy • Source: Alamy

More from Gene Therapies

More from Advanced Therapies